RecruitingPhase 1ketamine

Understanding Ketamine's Dissociative Effects (KD Study)

Sponsored by Stanford University

NCT ID
NCT04861051
Target Enrollment
20 participants
Start Date
2021-07-26
Est. Completion
2028-08-01

About This Study

The purpose of this study is to understand how ketamine brings about dissociative symptoms.

Conditions Studied

Epilepsy

Interventions

  • Ketamine

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Patient in Stanford Epilepsy Monitoring Unit
* Age \>18 years old.

Exclusion Criteria:

* Lifetime psychotic or bipolar disorder
* Inability to speak, read or understand English
* Pregnant or nursing females
* Prior adverse ketamine response

Study Locations (1)

Stanford University School of Medicine
Palo Alto, California, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source